RajeshTimGandhiMD
Infectious Disease • Boston, MAHIV/AIDS Medicine
Professor of Medicine, Harvard Medical School. Infectious Diseases Physician, Massachusetts General Hospital
Dr. Gandhi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Infectious Disease
Boston, MA 02114Phone+1 617-726-8403Fax+1 617-726-7653
Education & Training
Johns Hopkins UniversityFellowship, Infectious Disease, 1998 - 1999
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1993 - 1996- Brigham and Women's HospitalResidency, Internal Medicine, 1990 - 1993
Harvard Medical SchoolClass of 1990
Certifications & Licensure
MA State Medical License 1992 - 2025
MD State Medical License 1999 - 2000- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load Start of enrollment: 2007 Nov 01
- A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects Start of enrollment: 2009 Aug 01
- Sevelamer for Reducing Endotoxemia and Immune Activation Start of enrollment: 2011 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 230 citationsThe size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruptionJonathan Z. Li, Behzad Etemad, Hayat Ahmed, Evgenia Aga, Ronald J. Bosch
AIDS. 2015-11-01 - 111 citationsOrigin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy.Mary F. Kearney, Ann Wiegand, Wei Shao, John M. Coffin, John W. Mellors
Journal of Virology. 2016-02-01 - 61 citationsHIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollersRadwa Sharaf, Guinevere Q. Lee, Xiaoming Sun, Behzad Etemad, Layla M. Aboukhater
The Journal of Clinical Investigation. 2018-08-31
Journal Articles
- The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Post-Treatment Controllers Identified from 14 Clinical StudiesElizabeth Connick, Michael C Sneller, Jonathan Z Li, Paul Volberding, Daniel R Kuritzkes, Robert T Schooley, David Margolis, Daniel Skiest, John W Mellors, Ronald Mits..., The Journal of Infectious Diseases
- Antiretrovirals and Pregnancy: New Warnings Demand Close AttentionRajesh Gandhi, MD, NEJM Journal Watch
Other
- Review Promises and Pitfalls in the Reconstitution of Immunity in Patients Who Have HIV-1 InfectionRajesh Gandhi, MD, ScienceDirect
https://www.doximity.com/articles/91313802-bb90-4952-9a06-f5981fb2ae80
UpToDate, Wolters Kluwer Health - 2012-11-05
Authored Content
- Review Promises and Pitfalls in the Reconstitution of Immunity in Patients Who Have HIV-1 InfectionAugust 2002
Press Mentions
What Happens After COVID-19 Emergencies End?May 11th, 2023- Paxlovid for COVID-19: What Seniors Need to KnowJanuary 18th, 2023
- What Seniors Need to Know About Taking PaxlovidJanuary 17th, 2023
- Join now to see all
Grant Support
- ClinicalNational Institute Of Allergy And Infectious Diseases2009–2011
- Induction Of Hiv-Specific Immune ResponsesNational Institute Of Allergy And Infectious Diseases2006–2010
- Emicrobes: A Digital Library For Learning Infectious DiseasesNational Library Of Medicine2007–2009
- Mechanisms Of T Cell Apoptosis During HIV1 InfectionNational Institute Of Allergy And Infectious Diseases2000–2002
- Mechanisms Of T Cell Apoptosis During HIV1 InfectionNational Institute Of Allergy And Infectious Diseases1999
- Mechanisms Of T Cell Apoptosis During HIV1 InfectionNational Institute Of Allergy And Infectious Diseases1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
